Literature DB >> 16699859

Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.

Atsushi Nanashima1, Yorihisa Sumida, Takafumi Abo, Hisakazu Shindou, Hidetoshi Fukuoka, Hiroaki Takeshita, Shigekazu Hidaka, Kenji Tanaka, Terumitsu Sawai, Toru Yasutake, Takeshi Nagayasu, Katsuhisa Omagari, Mariko Mine.   

Abstract

BACKGROUND: We previously reported the effectiveness of the modified Cancer of the Liver Italian Program (CLIP) score in hepatocellular carcinoma (HCC) staging. To determine the best predictive staging system for HCC patients, we conducted a comparative analysis of prognosis using multivariate analysis in 230 Japanese HCC patients following hepatic resection.
METHODS: We compared overall survival as predicted by different staging systems: the tumor node metastasis (TNM) system by the Liver Cancer Study Group of Japan, the Japan Integrated Staging (JIS) score (Japanese TNM and Child-Pugh classification), the modified JIS score using liver damage grade, the CLIP score, and our modified CLIP score using protein induced by vitamin K absence or the antagonist II (PIVKA-II).
RESULTS: By a univariate analysis the PIVKA-II level (cut-off level, 400 mAU/ml) was significantly associated with patient survival (P = 0.031); however, alpha-fetoprotein level was not related to survival. Liver damage grade was significantly associated with patient survival (P = 0.039), although Child-Pugh classification was not related to survival. Univariate analysis showed that prediction of survival, according to disease stage, was better with the modified JIS score than with the TNM system, CLIP, modified CLIP, or JIS score. Multivariate analysis showed the modified JIS score showed the best ability to predict overall survival according to disease stage (Hazard ratio, 1.77; P = 0.002), and its Akaike information criteria statistic was the lowest (634.3).
CONCLUSIONS: The modified JIS score, a staging system that combines tumor factors and hepatic function, is a better predictor of prognosis than other systems in HCC patients who have undergone hepatic resection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699859     DOI: 10.1007/s00535-005-1751-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.

Authors:  R Tateishi; H Yoshida; S Shiina; H Imamura; K Hasegawa; T Teratani; S Obi; S Sato; Y Koike; T Fujishima; M Makuuchi; M Omata
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.

Authors:  A Nanashima; K Omagari; S Tobinaga; K Shibata; Y Sumida; M Mine; S Morino; S Shibasaki; N Ide; H Shindou; T Nagayasu
Journal:  Eur J Surg Oncol       Date:  2005-10       Impact factor: 4.424

Review 4.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

5.  A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Authors:  S Chevret; J C Trinchet; D Mathieu; A A Rached; M Beaugrand; C Chastang
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

6.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

8.  Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.

Authors:  Katsuhisa Omagari; Sumihisa Honda; Yoshiko Kadokawa; Hajime Isomoto; Fuminao Takeshima; Kenji Hayashida; Yohei Mizuta; Ikuo Murata; Shigeru Kohno
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

9.  Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.

Authors:  A Nanashima; S Morino; H Yamaguchi; K Tanaka; S Shibasaki; T Tsuji; S Hidaka; T Sawai; T Yasutake; T Nakagoe
Journal:  Eur J Surg Oncol       Date:  2003-11       Impact factor: 4.424

10.  Predetermining postoperative hepatic function for hepatectomies.

Authors:  T Takasaki; S Kobayashi; S Suzuki; H Muto; M Marada; Y Yamana; T Nagaoka
Journal:  Int Surg       Date:  1980 Jul-Aug
View more
  17 in total

1.  What is the best staging system for hepatocellular carcinoma?

Authors:  Masatoshi Kudo
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

2.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

3.  Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.

Authors:  Doo Yeul Lee; Joong-Won Park; Tae Hyun Kim; Ju Hee Lee; Bo Hyun Kim; Sang Myung Woo; Sang Soo Kim; Woo Jin Lee; Dae Yong Kim; Chang-Min Kim
Journal:  Strahlenther Onkol       Date:  2015-07-15       Impact factor: 3.621

Review 4.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 5.  Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.

Authors:  Jan Hansmann; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

6.  A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.

Authors:  Yukio Tokumitsu; Kazuhiko Sakamoto; Yoshihiro Tokuhisa; Hiroto Matsui; Satoshi Matsukuma; Yoshinari Maeda; Koichiro Sakata; Hiroshi Wada; Hidetoshi Eguchi; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Norio Iizuka; Tomio Ueno; Hiroaki Nagano
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

7.  Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival.

Authors:  Atsushi Nanashima; Naota Taura; Takafumi Abo; Tatsuki Ichikawa; Ichiro Sakamoto; Takeshi Nagayasu; Kazuhiko Nakao
Journal:  Dig Dis Sci       Date:  2011-06-25       Impact factor: 3.199

Review 8.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

9.  Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.

Authors:  Kai-Zhong Luo; Toshiyuki Itamoto; Hironobu Amano; Akihiko Oshita; Yuichiro Ushitora; Yoshisato Tanimoto; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

10.  Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score.

Authors:  Atsushi Nanashima; Junichi Masuda; Satoshi Miuma; Yorihisa Sumida; Takashi Nonaka; Kenji Tanaka; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.